Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
Ventyx Biosciences (Nasdaq: VTYX), a clinical-stage biopharmaceutical company developing novel oral therapies for inflammatory diseases, has announced its participation in two upcoming investor conferences:
1. 2024 Wells Fargo Healthcare Conference in Boston, MA on September 4, 2024, from 11:00-11:35 AM ET.
2. Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on September 6, 2024, from 1:05-1:40 PM ET.
Webcasts of the presentations will be available on the Ventyx website (www.ventyxbio.com) in the Investors and News section. Replays will be accessible for thirty days after the events.
Ventyx Biosciences (Nasdaq: VTYX), un'azienda biofarmaceutica in fase clinica che sviluppa nuove terapie orali per malattie infiammatorie, ha annunciato la sua partecipazione a due prossime conferenze per investitori:
1. Conferenza Sanitaria Wells Fargo 2024 a Boston, MA, il 4 settembre 2024, dalle 11:00 alle 11:35 ET.
2. 22a Conferenza Sanitaria Globale Annuale di Morgan Stanley a New York, NY, il 6 settembre 2024, dalle 13:05 alle 13:40 ET.
Le trasmissioni in diretta delle presentazioni saranno disponibili sul sito web di Ventyx (www.ventyxbio.com) nella sezione Investitori e Notizie. Le registrazioni saranno accessibili per trenta giorni dopo gli eventi.
Ventyx Biosciences (Nasdaq: VTYX), una empresa biofarmacéutica en etapa clínica que desarrolla nuevas terapias orales para enfermedades inflamatorias, ha anunciado su participación en dos próximas conferencias para inversores:
1. Conferencia de Salud Wells Fargo 2024 en Boston, MA, el 4 de septiembre de 2024, de 11:00 a 11:35 AM ET.
2. 22ª Conferencia Global Anual de Salud de Morgan Stanley en Nueva York, NY, el 6 de septiembre de 2024, de 1:05 a 1:40 PM ET.
Los webcasts de las presentaciones estarán disponibles en el sitio web de Ventyx (www.ventyxbio.com) en la sección de Inversores y Noticias. Las repeticiones estarán accesibles por treinta días después de los eventos.
Ventyx Biosciences (Nasdaq: VTYX)는 염증 질환을 위한 새로운 경구 요법을 개발하는 임상 단계의 생명공학 회사로, 두 개의 다가오는 투자자 회의에 참석한다고 발표했습니다:
1. 2024 웰스 파고 헬스케어 컨퍼런스가 MA주 보스턴에서 2024년 9월 4일 오전 11:00부터 11:35까지 ET에 열립니다.
2. 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스가 NY주 뉴욕에서 2024년 9월 6일 오후 1:05부터 1:40까지 ET에 개최됩니다.
프레젠테이션의 웹캐스트는 Ventyx 웹사이트(www.ventyxbio.com)의 투자자 및 뉴스 섹션에서 확인할 수 있습니다. 이벤트 후 30일 동안 다시 볼 수 있습니다.
Ventyx Biosciences (Nasdaq: VTYX), une entreprise biopharmaceutique en phase clinique développant de nouvelles thérapies orales pour les maladies inflammatoires, a annoncé sa participation à deux conférences pour investisseurs à venir :
1. Conférence sur la santé Wells Fargo 2024 à Boston, MA, le 4 septembre 2024, de 11h00 à 11h35 ET.
2. 22ème Conférence mondiale annuelle sur la santé de Morgan Stanley à New York, NY, le 6 septembre 2024, de 13h05 à 13h40 ET.
Les webcasts des présentations seront disponibles sur le site Web de Ventyx (www.ventyxbio.com) dans la section Investisseurs et Actualités. Les rediffusions seront accessibles pendant trente jours après les événements.
Ventyx Biosciences (Nasdaq: VTYX), ein biopharmazeutisches Unternehmen in der klinischen Phase, das neuartige orale Therapien für Entzündungskrankheiten entwickelt, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt:
1. 2024 Wells Fargo Gesundheitskonferenz in Boston, MA am 4. September 2024, von 11:00 bis 11:35 Uhr ET.
2. 22. Jährliche Globale Gesundheitskonferenz von Morgan Stanley in New York, NY am 6. September 2024, von 13:05 bis 13:40 Uhr ET.
Webcasts der Präsentationen sind auf der Ventyx-Website (www.ventyxbio.com) im Bereich Investoren und Nachrichten verfügbar. Die Aufzeichnungen sind 30 Tage nach den Veranstaltungen abrufbar.
- None.
- None.
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:
- Event: 2024 Wells Fargo Healthcare Conference
Location: Boston, MA
Date: Wednesday, September 4, 2024
Time: 11:00-11:35 AM ET
- Event: Morgan Stanley 22nd Annual Global Healthcare Conference
Location: New York, NY
Date: Friday, September 6, 2024
Time: 1:05-1:40 PM ET
A webcast of the presentations will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.
About Ventyx Biosciences
Ventyx is a clinical-stage biopharmaceutical company focused on advancing novel oral therapies for patients living with inflammatory diseases. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift inflammation markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting NLRP3, S1P1R and TYK2, positioning us to become a leader in the development of oral therapies for peripheral and neuroinflammatory diseases. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit www.ventyxbio.com.
Investor Relations Contact
Patti Bank
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com
FAQ
When is Ventyx Biosciences (VTYX) presenting at the Wells Fargo Healthcare Conference in 2024?
What is the date and time of Ventyx Biosciences' (VTYX) presentation at the Morgan Stanley Global Healthcare Conference in 2024?
How can investors access the webcasts of Ventyx Biosciences' (VTYX) presentations at the upcoming conferences?
How long will the replays of Ventyx Biosciences' (VTYX) conference presentations be available?
